Overweight and ObesityNCT03037567
Evaluation of a Commercial Program on Weight Loss and Health Outcomes
A study testing Modified Weight Watchers plan in people with Overweight and Obesity, run by University of North Carolina, Chapel Hill at 1 site in United States.
Trial summary
The purpose of this study is to examine the acceptability and efficacy of a modified Weight Watchers program over 24 weeks. Assessments will be conducted at 0, 3, and 6 months. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Overweight and Obesity
- What is being tested?
- Modified Weight Watchers plan
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 152 participants
- Where
- 1 siteUnited States
- Study dates
- 27 Jan 2017to 31 Aug 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Body mass index (BMI) between 25 and 43 kg/m²
- Ability to read and speak English
- All ethnic groups will be recruited
- Self-report desire to lose weight and willing to follow study recommendations
- Use of an iPhone with iOS 8.0 or later for use on a daily basis, and basic app skills
- Have access to the internet via a computer, and basic computer skills
Who cannot join
- Currently following a commercial weight-loss program (including Weight Watchers) or who followed a weight loss program in the previous 6 months or who were members of Weight Watchers within the past 12 months
- Another member of the household participating in the study.
- Pregnant or nursing, or planning on becoming pregnant over the next 9 months.
- Planning to relocate in the next 9 months
- Involvement in another research study that would interfere with participation in this study
- Excessive alcohol intake or dependence
Show all 19Show fewer
- Recent weight loss of ≥ 5 kg in the previous 6 months.
- Report health problems that make weight loss or unsupervised exercise unsafe or unreasonable (e.g., orthopedic limitations, heart problems, history or heart attack or stroke)
- History of clinically diagnosed eating disorder.
- Untreated thyroid disease or and changes in dose or type of thyroid medication over previous 6 months
- Chronic/inflammatory gastrointestinal disorders (Irritable Bowel Syndrome acceptable)
- Taking any prescription medication with known effects on appetite or weight
- Previous surgical procedure for weight loss.
- Major surgery within the previous 6 months.
- Resting systolic blood pressure >160 mmHg or resting diastolic blood pressure >100 mmHg
- Diuretic use over 1.5mg per day
- Diagnosis of type 1 or type 2 diabetes
- Presence of implanted cardiac defibrillator or pacemaker.
- History of presence of cancer within past 5 years or current treatment for cancer (completely resected basal or squamous cell carcinoma acceptable if treatment
Trial locations and contacts
1 site in 1 country.
United States1 site
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27514
About this study
The purpose of this study is to examine the acceptability and efficacy of a modified Weight Watchers program over 24 weeks. Assessments will be conducted at 0, 3, and 6 months.
Read the detailed description
The following assessment measures will be taken at 0, 3, and 6 months:
Weight measurements. Weight will be taken according to the National Health and Nutrition Examination survey anthropometry procedures manual. Weight will be measured in kilograms to the nearest 0.1 kg using a calibrated digital scale (Tanita, Inc.) with participants in light clothing and no shoes. Two measurements will be taken. and if the measures differ by more than 0.2 kg, a third measure will be taken. An average of the closest two measures will be calculated and used for data entry.
Waist circumference. Waist circumference will be assessed at baseline, 3 and 6 months. Waist circumference will be taken according to the National Health and Nutrition Examination survey anthropometry procedures manual. Measurements will be taken to the nearest 0.1cm, at the top of the pelvis ilium (just above the hip bone) with a non-stretchable tape measure, without compressing the skin, at the end of normal expiration. Two measurements will be taken with a third if the first two do not fall within 0.5 cm.
Aerobic stamina. Aerobic stamina will be assessed using the 6 minute walk test. Distance traveled in meters (m) is the outcome.
Flexibility. Flexibility will be assessed with the Classic Sit and Reach Test and reported in inches less than or greater than reached on a 20 inch reference mark as measured on a yard stick placed between the legs.
Food Cravings. The Food Craving Inventory-II (FCI-II) is a validated self-report measure for general cravings and cravings for specific types of foods and will be completed at baseline, Months 3 and 6. Respondents rate the frequency of cravings since the last time they completed the survey for each of 33 food items using a five-point Likert scale (1, never; 2, rarely; 3, sometimes; 4, often; 5, always/almost every day). The FCI-II consists of 5 scales (sweets, high fats, carbohydrates/starches, fast food fats, and fruits \& vegetables) that constitute the higher order construct of food cravings (the total score).
Happiness. The Oxford Happiness Questionnaire will be used to assess happiness at 0, 3, and 6 months. The OHQ is a validated self-report measure for broad personal happiness. Respondents rate 29 sentences on a 6 point Likert scale (1, strongly disagree; 6, strong agree).
Sleep. Participants will be asked to complete the Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality and duration at 0, 3, 6. The PSQI is a validated self-report measure of sleep duration and sleep quality. The PSQI examines seven components of sleep quality retrospectively over a period of four weeks: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction over the last month. The patient self-rates each of these seven areas of sleep. Scoring of answers is based on a 0-3 scale, whereby '3' reflects the negative extreme on the Likert scale. The global score is generated by summing up all seven component scores and ranges from 0 to 21, with higher values corresponding to reduced sleep quality.
Weight related quality of life. The Impact of Weight on Quality of Life-Lite (IWQOL-Lite) is a validated self-report measure for an individual's perception of how their weight affects their day-to-day life. Respondents rate the degree to which their weight affects them on 31 items using a five-point Likert scale (1, never true; 2, rarely true; 3, sometimes true; 4, usually true; 5, always true). The IWQOL-Lite consists of 5 scales (physical function, self-esteem, sexual life, public distress, and work).
Perceived Hunger. The Visual Analogue Scale (VAS) measures sensations that range across a continuum of values and cannot be easily directly measured. Operationally, the VAS is a horizontal line measuring exactly 100 mm in length, anchored by word descriptors (i.e., Not at all hungry, Extremely hungry) at each end. Participants will be asked to complete a three item VAS by placing a mark on the line at the point they feel represents their response to the question.
Program Satisfaction. The Satisfaction Survey is a self-administered survey with 25 items scored on a 5-point Likert scale. This measure will be completed at only at 6 months.
- Conditions
- Overweight and Obesity
- Being tested
- Modified Weight Watchers plan
- Medical subject headings
- Overweight, Obesity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Modified Weight Watchers planBehavioural
Weight Watchers is a structured lifestyle modification program that includes a food plan based on balanced diet and healthy eating, activity plan designed to promote progressive physical activity increase, group support and cognitive behavior modification. Participants attend weekly in-person group meetings led by a trained Weight Watchers meeting leader and have a suite of electronic tools available through an iPhone app.
| Study group | Role | What they receive |
|---|---|---|
| Modified Weight Watchers plan | Experimental | Modified Weight Watchers Plan which includes a food plan, activity plan, group support and cognitive behavior modification. Weekly study-specific group meetings; electronic tools through iPhone app for 24 weeks. Receives: Behavioral: Modified Weight Watchers plan |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight Change
Mean Change in body weight (kg) Body weight will be assessed on a calibrated digital scale and recorded to the nearest 0.1 kg.
Measured: 0 - 6 months
Secondary outcomes (6)
Achieving a weight loss of 5% or more
% participants achieving a weight loss of 5% initial body weight or more
Measured: 0 - 6 months
Achieving a weight loss of 5% or more
% participants achieving a weight loss of 5% initial body weight or more
Measured: 0 - 3 months
Weight Change
Mean Change in body weight (kg)
Measured: 0 - 3 months
Waist circumference change (cm) (mean)
Waist circumference will be measured at the iliac crest
Measured: 0 - 3 months
Waist circumference change (cm) (mean)
Waist circumference will be measured at the iliac crest
Measured: 0 - 6 months
Relationship between fitness, flexibility and psychosocial measures with weight change
The relationship between weight change and any of these measures will be assessed.
Measured: 0 - 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jan 2017 (estimated)
- Study start27 Jan 2017
- Primary completion31 Aug 2017
- Study completion31 Aug 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Overweight and ObesityStudies of the same condition, open and under way.
- More trials run by University of North Carolina, Chapel HillThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 152 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of North Carolina, Chapel Hill
- Sponsor type
- University, hospital or other
- Collaborators
- WW International Inc
- Responsible party
- Sponsor
- Investigators
- Deborah F Tate, PhD, Principal investigator, University of North Carolina, Chapel Hill
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03037567
- Sponsor's protocol ID
- 16-3421
- Status last verified
- May 2018
- First submitted
- 27 Jan 2017
- Last updated
- 18 May 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of a Commercial Program on Weight Loss and Health Outcomes
- ClinicalTrials.gov ID
- NCT03037567
- Acronym / sponsor ID
- 16-3421
- Conditions
- Overweight and Obesity
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 152 participants (actual)
- Lead sponsor
- University of North Carolina, Chapel HillUniversity, hospital or other
- Collaborators
- WW International Inc
- Study start
- 27 Jan 2017 (actual)
- Primary completion
- 31 Aug 2017 (actual)
- Study completion
- 31 Aug 2017 (actual)
- First posted
- 31 Jan 2017 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to examine the acceptability and efficacy of a modified Weight Watchers program over 24 weeks. Assessments will be conducted at 0, 3, and 6 months.
Detailed description
The following assessment measures will be taken at 0, 3, and 6 months:
Weight measurements. Weight will be taken according to the National Health and Nutrition Examination survey anthropometry procedures manual. Weight will be measured in kilograms to the nearest 0.1 kg using a calibrated digital scale (Tanita, Inc.) with participants in light clothing and no shoes. Two measurements will be taken. and if the measures differ by more than 0.2 kg, a third measure will be taken. An average of the closest two measures will be calculated and used for data entry.
Waist circumference. Waist circumference will be assessed at baseline, 3 and 6 months. Waist circumference will be taken according to the National Health and Nutrition Examination survey anthropometry procedures manual. Measurements will be taken to the nearest 0.1cm, at the top of the pelvis ilium (just above the hip bone) with a non-stretchable tape measure, without compressing the skin, at the end of normal expiration. Two measurements will be taken with a third if the first two do not fall within 0.5 cm.
Aerobic stamina. Aerobic stamina will be assessed using the 6 minute walk test. Distance traveled in meters (m) is the outcome.
Flexibility. Flexibility will be assessed with the Classic Sit and Reach Test and reported in inches less than or greater than reached on a 20 inch reference mark as measured on a yard stick placed between the legs.
Food Cravings. The Food Craving Inventory-II (FCI-II) is a validated self-report measure for general cravings and cravings for specific types of foods and will be completed at baseline, Months 3 and 6. Respondents rate the frequency of cravings since the last time they completed the survey for each of 33 food items using a five-point Likert scale (1, never; 2, rarely; 3, sometimes; 4, often; 5, always/almost every day). The FCI-II consists of 5 scales (sweets, high fats, carbohydrates/starches, fast food fats, and fruits \& vegetables) that constitute the higher order construct of food cravings (the total score).
Happiness. The Oxford Happiness Questionnaire will be used to assess happiness at 0, 3, and 6 months. The OHQ is a validated self-report measure for broad personal happiness. Respondents rate 29 sentences on a 6 point Likert scale (1, strongly disagree; 6, strong agree).
Sleep. Participants will be asked to complete the Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality and duration at 0, 3, 6. The PSQI is a validated self-report measure of sleep duration and sleep quality. The PSQI examines seven components of sleep quality retrospectively over a period of four weeks: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction over the last month. The patient self-rates each of these seven areas of sleep. Scoring of answers is based on a 0-3 scale, whereby '3' reflects the negative extreme on the Likert scale. The global score is generated by summing up all seven component scores and ranges from 0 to 21, with higher values corresponding to reduced sleep quality.
Weight related quality of life. The Impact of Weight on Quality of Life-Lite (IWQOL-Lite) is a validated self-report measure for an individual's perception of how their weight affects their day-to-day life. Respondents rate the degree to which their weight affects them on 31 items using a five-point Likert scale (1, never true; 2, rarely true; 3, sometimes true; 4, usually true; 5, always true). The IWQOL-Lite consists of 5 scales (physical function, self-esteem, sexual life, public distress, and work).
Perceived Hunger. The Visual Analogue Scale (VAS) measures sensations that range across a continuum of values and cannot be easily directly measured. Operationally, the VAS is a horizontal line measuring exactly 100 mm in length, anchored by word descriptors (i.e., Not at all hungry, Extremely hungry) at each end. Participants will be asked to complete a three item VAS by placing a mark on the line at the point they feel represents their response to the question.
Program Satisfaction. The Satisfaction Survey is a self-administered survey with 25 items scored on a 5-point Likert scale. This measure will be completed at only at 6 months.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Modified Weight Watchers plan | Experimental | Behavioral: Modified Weight Watchers planModified Weight Watchers Plan which includes a food plan, activity plan, group support and cognitive behavior modification. Weekly study-specific group meetings; electronic tools through iPhone app for 24 weeks. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Body mass index (BMI) between 25 and 43 kg/m²
- Ability to read and speak English
- All ethnic groups will be recruited
- Self-report desire to lose weight and willing to follow study recommendations
- Use of an iPhone with iOS 8.0 or later for use on a daily basis, and basic app skills
Key exclusion criteria (19 listed)
- Currently following a commercial weight-loss program (including Weight Watchers) or who followed a weight loss program in the previous 6 months or who were members of Weight Watchers within the past 12 months
- Another member of the household participating in the study.
- Pregnant or nursing, or planning on becoming pregnant over the next 9 months.
- Planning to relocate in the next 9 months
- Involvement in another research study that would interfere with participation in this study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Modified Weight Watchers planWeight Watchers is a structured lifestyle modification program that includes a food plan based on balanced diet and healthy eating, activity plan designed to promote progressive physical activity increase, group support and cognitive behavior modification. Participants attend weekly in-person group meetings led by a trained Weight Watchers meeting leader and have a suite of electronic tools available through an iPhone app. | Behavioural | Modified Weight Watchers plan |
Primary outcome
Weight Change
Time frame: 0 - 6 months
Mean Change in body weight (kg) Body weight will be assessed on a calibrated digital scale and recorded to the nearest 0.1 kg.
6 secondary outcomes
Achieving a weight loss of 5% or more
Time frame: 0 - 6 months
Achieving a weight loss of 5% or more
Time frame: 0 - 3 months
Weight Change
Time frame: 0 - 3 months
Waist circumference change (cm) (mean)
Time frame: 0 - 3 months
Waist circumference change (cm) (mean)
Time frame: 0 - 6 months
Relationship between fitness, flexibility and psychosocial measures with weight change
Time frame: 0 - 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2018.
- Individual participant dataSharing planned: No
Related trials for Overweight and Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Deborah F Tate, PhD principal investigator
University of North Carolina, Chapel Hill
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Modified Weight Watchers plan in people with Overweight and Obesity, run by University of North Carolina, Chapel Hill at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight Change (time frame: 0 - 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2018.